knowledge -WSS

knowledge

author：focus 2025-10-03 00:07:51 - browse：47525

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday released a new accounting of artificial intelligence tools cleared for use in health care, adding scores of new products designed to reshape care in several areas of medicine.

The update included 171 new products that use artificial intelligence and machine learning, including 155 authorized since August of 2022. The agency’s data indicate that, after a lull during the Covid-19 pandemic, the number of authorized devices in 2023 is expected to increase by more than 30% over the prior year.

The list of AI devices was first published after a STAT investigation reported that the FDA had failed to keep the public informed on its regulation of AI devices, or crucial details on the tests undertaken to prove their safety and effectiveness. The summary documents that describe new AI devices often fail to break out the demographics of the patients they were tested on, or where the testing took place, which makes it difficult for clinicians and patients to understand their potential biases and weaknesses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Study suggests new cause of Down syndrome: cells linked to aging

WSS

Medicare Advantage's lean provider networks lead CMS complaints

ASCO Daily Recap: CAR

'Little Tech' descents on D.C., wanting a say in how AI is regulated

Does Paxlovid work in people vaccinated against Covid

Physician assistants need a new name. Here's what it should be

ASCO Daily Recap: CAR

entertainment

knowledge

entertainment

How one medical school became remarkably diverse

Medicare Advantage coverage denials need scrutiny, senators say

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Illumina board agrees to spin off Grail, as divestment plans proceed

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Gene therapy denied for Afghan refugee whose father aided U.S.

Trump demands the U.S. pay no more for drugs than other countries … again

Medicare Advantage's lean provider networks lead CMS complaints

Sports medicine is finally prioritizing gender equality

American taxpayers paid $1.8 trillion in health care costs in 2022

Wikipedia

Medicare Advantage's lean provider networks lead CMS complaints

ASCO Takeaways: Winners, snoozers, and the art of cancer care

Fight over Supreme Court dialysis ruling puts kidney patients at risk

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Study suggests new cause of Down syndrome: cells linked to aging

JPM pitch from hospitals? Revenue streams outside of patient care

hotspot

hotspot

focus

hotspot